Suppr超能文献

肝硬化患者的营养评估

Nutritional assessment in patients with liver cirrhosis.

作者信息

Haj Ali Sara, Abu Sneineh Awni, Hasweh Reem

机构信息

Department of Internal Medicine, Faculty of Medicine, Al-Balqa Applied University, Salt 19117, Jordan.

Department of Gastroenterology and Hepatology, University of Jordan, Faculty of Medicine, Amman 11942, Jordan.

出版信息

World J Hepatol. 2022 Sep 27;14(9):1694-1703. doi: 10.4254/wjh.v14.i9.1694.

Abstract

Malnutrition is a liver cirrhosis complication affecting more than 20%-50% of patients. Although the term can refer to either nutrient deficiency or excess, it usually relates to undernutrition in cirrhosis settings. Frailty is defined as limited physical function due to muscle weakness, whereas sarcopenia is defined as muscle mass loss and an advanced malnutrition stage. The pathogenesis of malnutrition in liver cirrhosis is multifactorial, including decreased oral intake, maldigestion/malabsorption, physical inactivity, hyperammonemia, hypermetabolism, altered macronutrient metabolism and gut microbiome dysbiosis. Patients with chronic liver disease with a Body Mass Index of < 18.5 kg/m and/or decompensated cirrhosis or Child-Pugh class C are at the highest risk of malnutrition. For patients at risk of malnutrition, a detailed nutritional assessment is required, typically including a history and physical examination, laboratory testing, global assessment tools and body composition testing. The latter can be done using anthropometry, cross-sectional imaging including computed tomography or magnetic resonance, bioelectrical impedance analysis and dual-energy X-ray absorptiometry. A multidisciplinary team should screen for and treat malnutrition in patients with cirrhosis. Malnutrition and sarcopenia are associated with an increased risk of complications and a poor prognosis in patients with liver cirrhosis; thus, it is critical to diagnose these conditions early and initiate the appropriate nutritional therapy. In this review, we describe the prevalence and pathogenesis of malnutrition in liver cirrhosis patients and discuss the best diagnostic approach to nutritional assessment for them.

摘要

营养不良是一种肝硬化并发症,影响超过20%-50%的患者。尽管该术语可指营养缺乏或过剩,但在肝硬化情况下通常指营养不足。衰弱被定义为由于肌肉无力导致的身体功能受限,而肌肉减少症被定义为肌肉量减少和严重营养不良阶段。肝硬化患者营养不良的发病机制是多因素的,包括口服摄入量减少、消化/吸收不良、身体活动不足、高氨血症、高代谢、常量营养素代谢改变和肠道微生物群失调。体重指数<18.5 kg/m²和/或失代偿性肝硬化或Child-Pugh C级的慢性肝病患者营养不良风险最高。对于有营养不良风险的患者,需要进行详细的营养评估,通常包括病史和体格检查、实验室检查、综合评估工具和身体成分检测。后者可通过人体测量、包括计算机断层扫描或磁共振成像的横断面成像、生物电阻抗分析和双能X线吸收法来完成。多学科团队应对肝硬化患者的营养不良进行筛查和治疗。营养不良和肌肉减少症与肝硬化患者并发症风险增加和预后不良相关;因此,早期诊断这些情况并启动适当的营养治疗至关重要。在本综述中,我们描述了肝硬化患者营养不良 的患病率和发病机制,并讨论了对他们进行营养评估的最佳诊断方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf3/9521456/aba2c4f3a99e/WJH-14-1694-g001.jpg

相似文献

1
Nutritional assessment in patients with liver cirrhosis.
World J Hepatol. 2022 Sep 27;14(9):1694-1703. doi: 10.4254/wjh.v14.i9.1694.
2
Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis.
Aliment Pharmacol Ther. 2020 Jan;51(1):64-77. doi: 10.1111/apt.15571. Epub 2019 Nov 8.
3
Nutrition and Muscle in Cirrhosis.
J Clin Exp Hepatol. 2017 Dec;7(4):340-357. doi: 10.1016/j.jceh.2017.11.001. Epub 2017 Nov 8.
4
Malnutrition in Patients with Liver Cirrhosis.
Nutrients. 2021 Feb 7;13(2):540. doi: 10.3390/nu13020540.
5
Clinical relevance of sarcopenia in patients with cirrhosis.
World J Gastroenterol. 2014 Jul 7;20(25):8061-71. doi: 10.3748/wjg.v20.i25.8061.
7
Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis.
Int J Mol Sci. 2020 Jul 28;21(15):5357. doi: 10.3390/ijms21155357.
8
Clinical Overview of Sarcopenia, Frailty, and Malnutrition in Patients With Liver Cirrhosis.
Gastroenterology Res. 2024 Apr;17(2):53-63. doi: 10.14740/gr1707. Epub 2024 Apr 30.
9
Assessing nutrition status, sarcopenia, and frailty in adult transplant recipients.
Nutr Clin Pract. 2024 Feb;39(1):14-26. doi: 10.1002/ncp.11107. Epub 2023 Dec 14.
10
Malnourished cirrhotic patient: what should we do?
Minerva Gastroenterol (Torino). 2021 Mar;67(1):11-22. doi: 10.23736/S2724-5985.20.02776-2.

引用本文的文献

2
Importance of comprehensive nutritional assessment in predicting survival in cirrhosis.
World J Hepatol. 2025 May 27;17(5):106606. doi: 10.4254/wjh.v17.i5.106606.
4
Role of Nutrition in the Management of Chronic Liver Disease.
Gastro Hep Adv. 2025 Jan 2;4(5):100613. doi: 10.1016/j.gastha.2024.100613. eCollection 2025.
5
Epidemiology, Controversies, and Dilemmas of Perioperative Nutritional Risk/Malnutrition: A Narrative Literature Review.
Risk Manag Healthc Policy. 2025 Jan 13;18:143-162. doi: 10.2147/RMHP.S496098. eCollection 2025.
6
is associated with normal muscle mass and is related with sarcopenia in cirrhosis.
Front Nutr. 2024 Oct 30;11:1438897. doi: 10.3389/fnut.2024.1438897. eCollection 2024.
7
Screening and assessment of malnutrition in patients with liver cirrhosis.
Front Nutr. 2024 Jul 18;11:1398690. doi: 10.3389/fnut.2024.1398690. eCollection 2024.
9
Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases.
Nutrients. 2023 Aug 7;15(15):3487. doi: 10.3390/nu15153487.

本文引用的文献

1
Evaluation of techniques used to assess skeletal muscle quantity in patients with cirrhosis.
Clin Nutr ESPEN. 2021 Aug;44:287-296. doi: 10.1016/j.clnesp.2021.05.029. Epub 2021 Jun 11.
3
Sarcopenia and frailty in decompensated cirrhosis.
J Hepatol. 2021 Jul;75 Suppl 1(Suppl 1):S147-S162. doi: 10.1016/j.jhep.2021.01.025.
4
Arm lean mass determined by dual-energy X-ray absorptiometry is superior to characterize skeletal muscle and predict sarcopenia-related mortality in cirrhosis.
Am J Physiol Gastrointest Liver Physiol. 2021 May 1;320(5):G729-G740. doi: 10.1152/ajpgi.00478.2020. Epub 2021 Mar 17.
5
Malnutrition in Patients with Liver Cirrhosis.
Nutrients. 2021 Feb 7;13(2):540. doi: 10.3390/nu13020540.
7
Intestinal sp. Imbalance Associated With the Occurrence of Childhood Undernutrition in China.
Front Microbiol. 2019 Nov 29;10:2635. doi: 10.3389/fmicb.2019.02635. eCollection 2019.
9
Nutritional Laboratory Markers in Malnutrition.
J Clin Med. 2019 May 31;8(6):775. doi: 10.3390/jcm8060775.
10
Prevalence and impact of sarcopenia in non-cirrhotic portal hypertension.
Liver Int. 2019 Oct;39(10):1937-1942. doi: 10.1111/liv.14160. Epub 2019 Jun 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验